291 related articles for article (PubMed ID: 29625893)
1. Interleukin-15 Complex Treatment Protects Mice from Cerebral Malaria by Inducing Interleukin-10-Producing Natural Killer Cells.
Burrack KS; Huggins MA; Taras E; Dougherty P; Henzler CM; Yang R; Alter S; Jeng EK; Wong HC; Felices M; Cichocki F; Miller JS; Hart GT; Johnson AJ; Jameson SC; Hamilton SE
Immunity; 2018 Apr; 48(4):760-772.e4. PubMed ID: 29625893
[TBL] [Abstract][Full Text] [Related]
2. Role of IL-10-producing regulatory B cells in control of cerebral malaria in Plasmodium berghei infected mice.
Liu Y; Chen Y; Li Z; Han Y; Sun Y; Wang Q; Liu B; Su Z
Eur J Immunol; 2013 Nov; 43(11):2907-18. PubMed ID: 23893352
[TBL] [Abstract][Full Text] [Related]
3. Toxoplasma gondii upregulates interleukin-12 to prevent Plasmodium berghei-induced experimental cerebral malaria.
Settles EW; Moser LA; Harris TH; Knoll LJ
Infect Immun; 2014 Mar; 82(3):1343-53. PubMed ID: 24396042
[TBL] [Abstract][Full Text] [Related]
4. NK cells and conventional dendritic cells engage in reciprocal activation for the induction of inflammatory responses during Plasmodium berghei ANKA infection.
Ryg-Cornejo V; Nie CQ; Bernard NJ; Lundie RJ; Evans KJ; Crabb BS; Schofield L; Hansen DS
Immunobiology; 2013 Feb; 218(2):263-71. PubMed ID: 22704523
[TBL] [Abstract][Full Text] [Related]
5. Critical role of IL-33 receptor ST2 in experimental cerebral malaria development.
Palomo J; Reverchon F; Piotet J; Besnard AG; Couturier-Maillard A; Maillet I; Tefit M; Erard F; Mazier D; Ryffel B; Quesniaux VF
Eur J Immunol; 2015 May; 45(5):1354-65. PubMed ID: 25682948
[TBL] [Abstract][Full Text] [Related]
6. Malaria-specific and nonspecific activation of CD8+ T cells during blood stage of Plasmodium berghei infection.
Miyakoda M; Kimura D; Yuda M; Chinzei Y; Shibata Y; Honma K; Yui K
J Immunol; 2008 Jul; 181(2):1420-8. PubMed ID: 18606696
[TBL] [Abstract][Full Text] [Related]
7. Host Resistance to Plasmodium-Induced Acute Immune Pathology Is Regulated by Interleukin-10 Receptor Signaling.
Claser C; De Souza JB; Thorburn SG; Grau GE; Riley EM; Rénia L; Hafalla JCR
Infect Immun; 2017 Jun; 85(6):. PubMed ID: 28396319
[TBL] [Abstract][Full Text] [Related]
8. IFN-γ-producing CD4+ T cells promote experimental cerebral malaria by modulating CD8+ T cell accumulation within the brain.
Villegas-Mendez A; Greig R; Shaw TN; de Souza JB; Gwyer Findlay E; Stumhofer JS; Hafalla JC; Blount DG; Hunter CA; Riley EM; Couper KN
J Immunol; 2012 Jul; 189(2):968-79. PubMed ID: 22723523
[TBL] [Abstract][Full Text] [Related]
9. Infection-Induced Resistance to Experimental Cerebral Malaria Is Dependent Upon Secreted Antibody-Mediated Inhibition of Pathogenic CD8
Shaw TN; Inkson CA; Villegas-Mendez A; Pattinson DJ; Strangward P; Else KJ; Draper SJ; Zeef LAH; Couper KN
Front Immunol; 2019; 10():248. PubMed ID: 30846985
[TBL] [Abstract][Full Text] [Related]
10. Filaria-induced IL-10 suppresses murine cerebral malaria.
Specht S; Ruiz DF; Dubben B; Deininger S; Hoerauf A
Microbes Infect; 2010 Aug; 12(8-9):635-42. PubMed ID: 20420933
[TBL] [Abstract][Full Text] [Related]
11. Parasite densities modulate susceptibility of mice to cerebral malaria during co-infection with Schistosoma japonicum and Plasmodium berghei.
Wang ML; Feng YH; Pang W; Qi ZM; Zhang Y; Guo YJ; Luo EJ; Cao YM
Malar J; 2014 Mar; 13():116. PubMed ID: 24670210
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: selective blockade of LIGHT-lymphotoxin beta receptor signaling protects mice from experimental cerebral malaria caused by Plasmodium berghei ANKA.
Randall LM; Amante FH; Zhou Y; Stanley AC; Haque A; Rivera F; Pfeffer K; Scheu S; Hill GR; Tamada K; Engwerda CR
J Immunol; 2008 Dec; 181(11):7458-62. PubMed ID: 19017933
[TBL] [Abstract][Full Text] [Related]
13. IL-12Rβ2 is essential for the development of experimental cerebral malaria.
Fauconnier M; Palomo J; Bourigault ML; Meme S; Szeremeta F; Beloeil JC; Danneels A; Charron S; Rihet P; Ryffel B; Quesniaux VF
J Immunol; 2012 Feb; 188(4):1905-14. PubMed ID: 22238458
[TBL] [Abstract][Full Text] [Related]
14. Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.
Howland SW; Poh CM; Gun SY; Claser C; Malleret B; Shastri N; Ginhoux F; Grotenbreg GM; Rénia L
EMBO Mol Med; 2013 Jul; 5(7):984-99. PubMed ID: 23681698
[TBL] [Abstract][Full Text] [Related]
15. Protection of Batf3-deficient mice from experimental cerebral malaria correlates with impaired cytotoxic T-cell responses and immune regulation.
Kuehlwein JM; Borsche M; Korir PJ; Risch F; Mueller AK; Hübner MP; Hildner K; Hoerauf A; Dunay IR; Schumak B
Immunology; 2020 Feb; 159(2):193-204. PubMed ID: 31631339
[TBL] [Abstract][Full Text] [Related]
16. Induction of pro-inflammatory mediators in Plasmodium berghei infected BALB/c mice breaks blood-brain-barrier and leads to cerebral malaria in an IL-12 dependent manner.
Schmidt KE; Schumak B; Specht S; Dubben B; Limmer A; Hoerauf A
Microbes Infect; 2011 Sep; 13(10):828-36. PubMed ID: 21609776
[TBL] [Abstract][Full Text] [Related]
17. IL-4Rα signaling by CD8α
Wu X; Brombacher F; Chroneos ZC; Norbury CC; Gowda DC
J Biol Chem; 2021; 296():100615. PubMed ID: 33798555
[TBL] [Abstract][Full Text] [Related]
18. NK Cell IL-10 Production Requires IL-15 and IL-10 Driven STAT3 Activation.
Clark SE; Burrack KS; Jameson SC; Hamilton SE; Lenz LL
Front Immunol; 2019; 10():2087. PubMed ID: 31552035
[TBL] [Abstract][Full Text] [Related]
19. Contribution of the Ly49E natural killer receptor in the immune response to Plasmodium berghei infection and control of hepatic parasite development.
Filtjens J; Foquet L; Taveirne S; Van Ammel E; Vanhees M; Van Acker A; Kerre T; Taghon T; Vandekerckhove B; Plum J; Van den Steen PE; Leclercq G
PLoS One; 2014; 9(1):e87463. PubMed ID: 24498110
[TBL] [Abstract][Full Text] [Related]
20. PDL1 Fusion Protein Protects Against Experimental Cerebral Malaria via Repressing Over-Reactive CD8
Wang J; Li Y; Shen Y; Liang J; Li Y; Huang Y; Liu X; Jiang D; Yang S; Zhao Y; Yang K
Front Immunol; 2018; 9():3157. PubMed ID: 30693001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]